Novacyt S.A.

NVYTF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$19,630$11,579$21,040$95,780
% Growth69.5%-45%-78%
Cost of Goods Sold-$12,444$7,849$15,294$66,102
Gross Profit$32,074$3,730$5,746$29,678
% Margin163.4%32.2%27.3%31%
R&D Expenses$2,767$3,228$5,047$4,815
G&A Expenses$40,239$4,884$4,856$6,810
SG&A Expenses$41,526$5,878$9,682$13,835
Sales & Mktg Exp.$1,287$994$4,826$7,025
Other Operating Expenses$25,124$24,140$7,619$12,395
Operating Expenses$69,417$33,246$22,348$31,045
Operating Income-$37,343-$29,516-$16,602-$1,367
% Margin-190.2%-254.9%-78.9%-1.4%
Other Income/Exp. Net-$2,087$948$3,340-$1,933
Pre-Tax Income-$39,430-$28,568-$20,053-$9,829
Tax Expense-$732-$768$2,148-$101
Net Income-$41,758-$28,292-$22,201-$9,728
% Margin-212.7%-244.3%-105.5%-10.2%
EPS-0.59-0.4-0.31-0.14
% Growth-47.5%-29%-121.4%
EPS Diluted-0.59-0.4-0.31-0.14
Weighted Avg Shares Out70,62670,62670,62670,626
Weighted Avg Shares Out Dil70,62670,62670,62670,626
Supplemental Information
Interest Income$3,034$735$782$33
Interest Expense$5,121$682$489$239
Depreciation & Amortization-$202$9,643$2,479$2,083
EBITDA-$34,309-$18,243-$11,677-$4,197
% Margin-174.8%-157.6%-55.5%-4.4%